Siraj M. Ali

Dr. Siraj M. Ali is a physician-scientist and VP of clinical development at EQRx, a Cambridge area biotechnology company. Previously, he led translational research efforts at Foundation Medicine where his group focused on identifying predictive biomarkers for targeted anti-neoplastic and cancer immunotherapies, which encompasses both work with basic cancer biology and exceptional responders. Siraj has co-authored more than 200 peer-reviewed manuscripts, which have accrued nearly 20,000 citations, in journals such as The Oncologist, JCO-Precision Oncology, Cancer Discovery, Journal of Clinical Oncology (JCO), and others. He has given invited and juried presentations at international conferences. Siraj serves as a reviewer for multiple life-sciences journals and is a member of a NIH study section focused on drug development for oncology.

Siraj earned his BS in Biophysics Phi Beta Kappa from the Johns Hopkins University and an MD-PhD program from Harvard Medical School supported by HHMI fellowships and the Medical Scientist Training Program. He completed residency training at the Beth Israel Deaconess Medical Center/Harvard Medical School in Boston and is board-certified in Anatomic Pathology.